Kirsten Castillo - 11 Aug 2022 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role: Director
Signature: /s/ Kirsten Castillo by Shankar Musunuri, her attorney-in-fact
Issuer symbol: OCGN
Transactions as of: 11 Aug 2022
Net transactions value: -$110,460
Form type: 4
Filing time: 12 Aug 2022, 16:49:39 UTC
Previous filing: 08 Jun 2022
Next filing: 26 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCGN	Common Stock	Options Exercise	$11,760	+42,000	+84%	$0.2800	92,000	11 Aug 2022	Direct
transaction	OCGN	Common Stock	Sale	$122,220	-42,000	-46%	$2.91^*	50,000	11 Aug 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCGN	Option (Right to Buy)	Options Exercise	$0	-42,000	-78%	$0.000000	12,000	11 Aug 2022	Common Stock	42,000	$0.2800	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.89 to $2.94. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2	The options, initially representing a right to purchase 54,000 shares, vest and become exercisable in equal monthly installments over three years commencing on May 5, 2020, subject to continued service with the Company on the applicable vesting dates.

Content

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.89 to $2.94. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The options, initially representing a right to purchase 54,000 shares, vest and become exercisable in equal monthly installments over three years commencing on May 5, 2020, subject to continued service with the Company on the applicable vesting dates.